1
van Schoonhoven, Alexander V., Schöttler, Marcel H., Serné, Erik H., Schrömbges, Patrick P.G., Postma, Maarten J., Boersma, Cornelis
Veröffentlicht in: van Schoonhoven , A V , Schöttler , M H , Serné , E H , Schrömbges , P P G , Postma , M J & Boersma , C 2023 , ' The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in The Netherlands ' , Journal of Medical Economics , vol. 26 , no. 1 , pp. 547-553 . https://doi.org/10.1080/13696998.2023.2194802;
2023
Veröffentlicht in: van Schoonhoven , A V , Schöttler , M H , Serné , E H , Schrömbges , P P G , Postma , M J & Boersma , C 2023 , ' The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in The Netherlands ' , Journal of Medical Economics , vol. 26 , no. 1 , pp. 547-553 . https://doi.org/10.1080/13696998.2023.2194802;
2023
2
Boersma, Cornelis, Broere, Adriaan, Postma, Maarten J.
Veröffentlicht in: Boersma , C , Broere , A & Postma , M J 2010 , ' Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis ' , Value in Health , vol. 13 , no. 6 , pp. 853-856 . https://doi.org/10.1111/j.1524-4733.2010.00736.x;
2010
Veröffentlicht in: Boersma , C , Broere , A & Postma , M J 2010 , ' Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis ' , Value in Health , vol. 13 , no. 6 , pp. 853-856 . https://doi.org/10.1111/j.1524-4733.2010.00736.x;
2010
3
Hepkema, Hiltsje, Pouwels, Koen B., van der Ende, Arie, Westra, Tjalke A., Postma, Maarten J.
Veröffentlicht in: Hepkema , H , Pouwels , K B , van der Ende , A , Westra , T A & Postma , M J 2013 , ' Meningococcal Serogroup A, C, W-135 and Y Conjugated Vaccine : A Cost-Effectiveness Analysis in the Netherlands ' , PLoS ONE , vol. 8 , no. 5 , e65036 . https://doi.org/10.1371/journal.pone.0065036;
2013
Veröffentlicht in: Hepkema , H , Pouwels , K B , van der Ende , A , Westra , T A & Postma , M J 2013 , ' Meningococcal Serogroup A, C, W-135 and Y Conjugated Vaccine : A Cost-Effectiveness Analysis in the Netherlands ' , PLoS ONE , vol. 8 , no. 5 , e65036 . https://doi.org/10.1371/journal.pone.0065036;
2013
4
Dolk, F. Christiaan K., de Boer, Pieter T., Nagy, Lisa, Donker, Ge A., Meijer, Adam, Postma, Maarten J., Pitman, Richard
Veröffentlicht in: Dolk , F C K , de Boer , P T , Nagy , L , Donker , G A , Meijer , A , Postma , M J & Pitman , R 2021 , ' Consultations for Influenza-Like Illness in Primary Care in The Netherlands : A Regression Approach ' , Value in Health , vol. 24 , no. 1 , pp. 11-18 . https://doi.org/10.1016/j.jval.2020.10.013;
2021
Veröffentlicht in: Dolk , F C K , de Boer , P T , Nagy , L , Donker , G A , Meijer , A , Postma , M J & Pitman , R 2021 , ' Consultations for Influenza-Like Illness in Primary Care in The Netherlands : A Regression Approach ' , Value in Health , vol. 24 , no. 1 , pp. 11-18 . https://doi.org/10.1016/j.jval.2020.10.013;
2021
5
van Wijhe, Maarten, de Boer, Pieter T., de Jong, Herman J., van Vliet, Hans, Wallinga, Jacco, Postma, Maarten J.
Veröffentlicht in: van Wijhe , M , de Boer , P T , de Jong , H J , van Vliet , H , Wallinga , J & Postma , M J 2019 , ' Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis ' , Vaccine , vol. 37 , no. 38 , pp. 5698-5707 . https://doi.org/10.1016/j.vaccine.2019.07.097;
2019
Veröffentlicht in: van Wijhe , M , de Boer , P T , de Jong , H J , van Vliet , H , Wallinga , J & Postma , M J 2019 , ' Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis ' , Vaccine , vol. 37 , no. 38 , pp. 5698-5707 . https://doi.org/10.1016/j.vaccine.2019.07.097;
2019
6
Rozenbaum, Mark H., De Cao, Elisabetta, Postma, Maarten J.
Veröffentlicht in: Rozenbaum , M H , De Cao , E & Postma , M J 2012 , ' Cost-effectiveness of pertussis booster vaccination in the Netherlands ' , Vaccine , vol. 30 , no. 50 , pp. 7327-7331 . https://doi.org/10.1016/j.vaccine.2012.06.026;
2012
Veröffentlicht in: Rozenbaum , M H , De Cao , E & Postma , M J 2012 , ' Cost-effectiveness of pertussis booster vaccination in the Netherlands ' , Vaccine , vol. 30 , no. 50 , pp. 7327-7331 . https://doi.org/10.1016/j.vaccine.2012.06.026;
2012
7
Pierik, Jorien G. J., Gumbs, Pearl D., Fortanier, Sander A. C., Van Steenwijk, Pauline C. E., Postma, Maarten J.
Veröffentlicht in: Pierik , J G J , Gumbs , P D , Fortanier , S A C , Van Steenwijk , P C E & Postma , M J 2012 , ' Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands ' , BMC Infectious Diseases , vol. 12 , 110 . https://doi.org/10.1186/1471-2334-12-110;
2012
Veröffentlicht in: Pierik , J G J , Gumbs , P D , Fortanier , S A C , Van Steenwijk , P C E & Postma , M J 2012 , ' Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands ' , BMC Infectious Diseases , vol. 12 , 110 . https://doi.org/10.1186/1471-2334-12-110;
2012
8
Postma, Maarten J., Novak, Annoesjka, Scheijbeler, Huib W. K. F. H., Gyldmark, Marlene, van Genugten, Marianne L. L., Wilschut, Jan C.
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
9
Eijsink, Job F. H., Al Khayat, Mohamed N. M. T., Boersma, Cornelis, ter Horst, Peter G. J., Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Eijsink , J F H , Al Khayat , M N M T , Boersma , C , ter Horst , P G J , Wilschut , J C & Postma , M J 2021 , ' Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 1 , pp. 75-88 . https://doi.org/10.1007/s10198-020-01236-2;
2021
Veröffentlicht in: Eijsink , J F H , Al Khayat , M N M T , Boersma , C , ter Horst , P G J , Wilschut , J C & Postma , M J 2021 , ' Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 1 , pp. 75-88 . https://doi.org/10.1007/s10198-020-01236-2;
2021
10
Westra, Tjalke A., Stirbu-Wagner, Irina, Dorsman, Sara, Tutuhatunewa, Eric D., de Vrij, Edwin L., Nijman, Hans W., Daemen, Toos, Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013